-
Product Insights
NewAspergillosis – Drugs In Development, 2024
Empower your strategies with our Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an infection or allergic response due to the Aspergillus fungus. Symptoms include cough, fever, headaches, general ill feeling (malaise), weight loss, and chest pain. The predisposing factors include weakened immune system, low white blood cell level, asthma, and long-term corticosteroid therapy. Treatment includes oral corticosteroids, antifungals, and surgery. The Aspergillosis drugs in development market research report provide comprehensive information on the...
-
Product Insights
NewAllergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024
Empower your strategies with our Allergic Bronchopulmonary Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic bronchopulmonary aspergillosis (ABPA) is infection of the lung with Aspergillus fumigatus fungus in those with bronchial asthma, cystic fibrosis, or a compromised immune system. The disease effects are caused by a hypersensitivity reaction to antigens of the Aspergillus species. Clinical manifestations include bronchospasm, pulmonary infiltrates, eosinophilia, and immunologic evidence of allergy to the antigens of Aspergillus species. The Allergic Bronchopulmonary...
-
Product Insights
NewSystemic Aspergillosis – Drugs In Development, 2024
Empower your strategies with our Systemic Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an opportunistic infection that usually affects the lower respiratory tract and is caused by inhaling spores of the filamentous fungus Aspergillus, commonly present in the environment. The spores germinate and develop into hyphae, which enter blood vessels and, with invasive disease, cause hemorrhagic necrosis and infarction. Symptoms may be those of asthma, pneumonia, sinusitis, or rapidly progressing systemic illness. The...